ResearchIn-Press PreviewDevelopmentNephrologyOncology
Open Access |
10.1172/jci.insight.188078
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by Adam, M. in: PubMed | Google Scholar
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by Drake, K. in: PubMed | Google Scholar
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by Pode-Shakked, N. in: PubMed | Google Scholar
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by VandenHeuvel, K. in: PubMed | Google Scholar
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by Potter, S. in: PubMed | Google Scholar
1Division of Experimental Hematology and Cancer Biology, Cancer and Blood Di, Cincinnati Children’s Hospital Medical Center, Cincinnati, United States of America
2Division of Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, United States of America
3Pediatric Nephrology Unit, Dana Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
4Division of Pathology and Laboratory Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
5Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, United States of America
6Division of Hematology/Oncology, Department of Pediatrics, Peckham Center for Cancer and Blood Disorders, Rady Children’s Hospital, San Diego, United States of America
Find articles by Geller, J. in: PubMed | Google Scholar
Published June 9, 2026 - More info
While Wilms tumors commonly arise from renal precursor cells and maintain features of the developing kidney, recent studies have demonstrated significant genetic, histologic, and molecular heterogeneity. To further investigate tumor variability as well as unifying features in tumor biology, we performed single nuclei RNA-sequencing (snRNA-seq) on treatment naïve, favorable histology Wilms tumors utilizing a reference atlas established from tumor-adjacent kidney samples and fetal kidney. Transcriptional profiles of blastemal, stromal, and epithelial components were correlated with tumor histology and demonstrate developmental-lineage plasticity, with PAX2 and PAX8 expression normally restricted to the nephron lineage of the fetal kidney found to be expressed in tumor stroma, as well as the stromal marker POSTN identified in tumor blastema. Further analyses of the blastema show shared transcriptional features with the differentiation trajectory of “uninduced” to “early differentiating” fetal nephron progenitor cells as well as aberrant expression of stromal signatures. A number of pathways from fetal nephron progenitors were maintained in the blastema, including regulation of stem cell maintainence and axonogenesis, whereas other pathways appear enriched in specific tumor samples, demonstrating the ability of snRNA-seq to identify both unifiying transcriptional signatures and uncover distinct molecular targets in signaling pathways and/or biological drivers of Wilms tumorigenesis.